tiprankstipranks
Is AKRO a Buy, Before Earnings?
PremiumPre-EarningsIs AKRO a Buy, Before Earnings?
14d ago
Akero Therapeutics reports Q3 EPS ($1.05), consensus (90c)
Premium
The Fly
Akero Therapeutics reports Q3 EPS ($1.05), consensus (90c)
16d ago
Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
Premium
The Fly
Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
23d ago
Akero Therapeutics reports Q2 EPS (81c), consensus (90c)
PremiumThe FlyAkero Therapeutics reports Q2 EPS (81c), consensus (90c)
4M ago
Class Action Lawsuit against Akero Therapeutics, Inc. (NASDAQ:AKRO)
Premium
Market News
Class Action Lawsuit against Akero Therapeutics, Inc. (NASDAQ:AKRO)
5M ago
Akero Therapeutics announces initiation of Phase 3 SYNCHRONY outcomes trial
Premium
The Fly
Akero Therapeutics announces initiation of Phase 3 SYNCHRONY outcomes trial
6M ago
Akero Therapeutics price target lowered to $56 from $59 at Canaccord
PremiumThe FlyAkero Therapeutics price target lowered to $56 from $59 at Canaccord
7M ago
Akero Therapeutics files automatic mixed securities shelf
Premium
The Fly
Akero Therapeutics files automatic mixed securities shelf
7M ago
Akero Therapeutics reports Q1 EPS (90c), consensus (95c)
Premium
The Fly
Akero Therapeutics reports Q1 EPS (90c), consensus (95c)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100